ArticleMolecular therapy. Methods & clinical development2022

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients.

Lena Peter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.